TITLE

NICOTINIC ACID IN THE TREATMENT OF HYPERCHOLESTEROLEMIA

AUTHOR(S)
Charman, Robert C.; Matthews, Louis B.; Braeuler, Charlotte
PUB. DATE
January 1972
SOURCE
Angiology;Jan1972, Vol. 23 Issue 1, p29
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
One hundred and sixty patients were treated with nicotinic acid for hypercholesterolemia and followed for periods up to twelve years. The mean percentage decrease of serum cholesterol was 26%. The majority of dropouts occurred during the early phases of treatment. The major side effects demonstrated were gastrointestinal symptoms including a 5.6% incidence of peptic ulcer. No evidence of serious irreversible side effects was demonstrated in a total 868 patient- years of treatment. Although side effects are a definite deterrent to some users of nicotinic acid, the drug is still of major importance in the therapy of hypercholesterolemia.
ACCESSION #
16357608

 

Related Articles

  • Perforated Peptic Ulcer Treated by Simple Closure and Helicobacter Pylori Eradication. Rodríguez-Sanjuán, Juan C.; Fernández-Santiago, Roberto; García, Rosa A.; Trugeda, Soledad; Seco, Isabel; la de Torre, Fernando; Naranjo, Angel; Gómez-Fleitas, Manuel // World Journal of Surgery;Jul2005, Vol. 29 Issue 7, p849 

    Simple closure followed by Helicobacter pylori (Hp) eradication has become the most used procedure in perforated ulcer treatment. However, its efficacy and safety are still to be determined. In assess recurrence and re-perforation rates, and as a secondary objective, to analyze Hp infection...

  • 19a: Dyspepsia: GORD and peptic ulcers. Brown, Patricia // Practice Nurse;1/28/2005, Vol. 29 Issue 2, p46 

    Presents information on dyspepsia, gastro-oesophageal reflux and peptic ulcer. Description of the gastrointestinal diseases; Incidence and causes; Information on the treatment and management of the diseases.

  • A 'burning' question is how to fit DM into ulcer treatment programs. Mulligan, Margaret // Managed Healthcare;May99, Vol. 9 Issue 5, p32 

    Focuses on the incorporation of disease management into ulcer treatment programs in the United States. Development of protocols and disease-management programs; Etiology of ulcer.

  • Haematemesis and melaena--a permanent problem.  // British Medical Journal;4/16/1977, Vol. 1 Issue 6067, p989 

    Reports the high incidence of peptic ulcer. Relationship between the occurrence of the condition and stress of urban living; Reaction to medical treatment; Importance of early diagnosis and treatment.

  • Treatment of nonvariceal upper gastrointestinal bleeding. Rivkin, Kirill; Lyakhovetskiy, Aleksandr // American Journal of Health-System Pharmacy;6/1/2005, Vol. 62 Issue 11, p1159 

    Purpose. The etiology, pathophysiology, prognostic factors, pharmacologic treatment, and pharmacoeconomic considerations of nonvariceal upper-gastrointestinal-tract bleeding (UGB) are reviewed. Summary. UGB is associated with substantial morbidity and mortality. While UGB can be caused by a wide...

  • Giant Antral Ulcer: A Rare Presentation of Eosinophilic Gastroenteritis--Case Report and Review of the Literature. Kristopaitis, Theresa; Neghme, Carlos; Yong, Sherri L.; Chejfee, Gregorio; Aranha, Gerard; Keshavarzian, Ali // American Journal of Gastroenterology;Jul1997, Vol. 92 Issue 7, p1205 

    A 24-yr-old female presented with a giant gastric ulcer and anemia. She suffered from a transient infantile malabsorption syndrome with eosinophilia. The diagnosis of eosinophilic gastroenteritis associated with the gastric ulcer was made by endoscopic biopsy. Ulcer healing was refractory to...

  • MANAGEMENT OF DYSPEPSIA AND PEPTIC ULCER DISEASE. Ryan, Susan W. // Alternative Therapies in Health & Medicine;Sep/Oct2005, Vol. 11 Issue 5, p26 

    Discusses the management of dyspepsia and peptic ulcer disease. Medications and foods that are known to contribute to the conditions; Prevalence and causes; Diagnostic testing.

  • Comparison of Clinical Features and Patient Background in Functional Dyspepsia and Peptic Ulcer. Hiroko Nakao; Hideyuki Konishi; Shoji Mitsufuji; Junko Yamauchi; Takeshi Yasu; Junko Taniguchi; Naoki Wakabayashi; Keisho Kataoka; Takeshi Okanoue // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2152 

    Abstract  To elucidate the clinical features of functional dyspepsia (FD), patients with FD were compared with patients with peptic ulcer. Fifty-eight FD and fifty-nine peptic ulcer patients were compared with respect to clinical features and patient background. In the FD group,...

  • Indigestion: When is it functional? Talley, Nicholas J; Nghi Phung; Kalantar, Jamshid S // BMJ: British Medical Journal (International Edition);12/1/2001, Vol. 323 Issue 7324, p1294 

    Discusses the diagnosis and treatment of dyspepsia. Various symptoms of the condition, including heartburn, abdominal pain, and acid regurgitation; Causes of dyspepsia, including gastro-esophageal reflux disease, peptic ulcers, gastric cancer, and gall stones; Pathogenesis, identification and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics